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defined as the first hospitalization with a diagnosis of chronic kidney
disease.
Results: At baseline, 146 (19%) and 60 (7.6%) patients met metabolic
syndrome and microalbuminuria criteria, respectively. After a median
follow-up of 11.6 years, renal end-point was reached in 15.8% of patients
with metabolic syndrome and in 8.9% of those without it (P! 0.0087). The
risk of renal events increased progressively starting from patients with
neither metabolic syndrome nor microalbuminuria, to patients with only
one of these abnormalities, and then to those with both. Significant
interaction was observed between metabolic syndrome and microalbumi-
nuria. Patients with concomitant occurrence of metabolic syndrome and
microalbuminuria at baseline showed a greater than 5-fold risk of renal
outcome as compared to patients with neither of these two risk factors. This
risk became even higher when data were adjusted for potential con-
founders.
Conclusions: Metabolic syndrome and microalbuminuria are independent
and interactive predictors of renal outcome in non diabetic patients with
primary hypertension.
2D.04 ARE 3 SAMPLES MANDATORY TO CONFIRM A
MICROALBUMINURIA?
J. Fauvel, S. Lepenven, M. Ducher. Université C Bernard, Hospices Civils de
Lyon, Lyon, France
Objective: Urinary albumin excretion is subject to an intra individual
variability. Thus, for research purposes, it is recommended to assay micro-
albuminuria on three urine samples collected over a short time interval. The
objective of our analysis was to check the usefulness to triplicate samples to
make sure of the albuminuric status of a diabetic patient.
Methods: Microalbuminuria is a urinary excretion of albumin to creatinin
ratio (ACR) between 2.5 and 25mg/mmol creat in man and between 3.5 and
35mg/mmol of creatinine in woman. Lower and upper thresholds are usually
called normoalbuminuria and macroalbuminuria respectively. We present
the not planed retrospective analysis of 82 triplicates (3 consecutive days)
morning urine samples obtained during the follow-up of 47 type 2 diabetics
(85 % hypertensives) who participated in 3 international studies (ROAD-
MAP, AVOID, ALTITUDE). All the measurements (immunoturbidimetry)
were performed on fresh urines in the same laboratory. Concordance was
obtained if the second andor the third sample confirmed the albuminuric
status obtained from the first sample.
Results: 17 % of the patients were normoalbuminuric, 27 % microalbumi-
nuric and 56 % macroalbuminuric. Mean ACR"SEM for the 3 successive
samples were 76" 10, 70" 9 and 72" 9mg/mmol creat. The concordance
rate was 98.8 %. Only a man whose ACR was close to the microalbuminuric
upper threshold had 2 clashing values in the successive samples. The
coefficient of variation of the immunoturbidimetric method (4 %) widely
explains this result.
Conclusion: Our results clearly show that it is useless to repeat albuminuria
measurements to define the albuminuric status of hypertensive diabetics
subjects.
2D.05 PROXIMAL SODIUM REABSORPTION
IS AN INDEPENDENT PREDICTOR OF
HYPERTENSION
F. Galletti, L. D’Elia, D. De Palma, R. Ippolito, R. Iacone, G. Rossi,
S. Avallone, P. Strazzullo. Department of Clinical & Experimental Medicine,
Federico II University of Naples, Naples, Italy
Objective: Given the association between salt-sensitivity of blood pressure
(BP) and risk of future hypertension (HPT), we investigated the predictive
role of alterations in segmental renal tubular sodium handling in the
development of HPT during the 8 year follow-up of the Olivetti Heart
Study participants.
Methods: A selected sample (n! 314) of OHS population was
examined at baseline and after 8 years. The participants were included
if they were normotensive (SBP/DBP <140/90mm Hg without anti-
hypertensive treatment) and had normal renal function (creatinine clear-
ance - CrCl> 60ml/min) at baseline. Proximal and distal fractional tubular
sodium reabsorption were calculated using the clearance of exogenous
lithium.
Results: The baseline sample characteristics were: age 49.3" 6.8 yrs, BMI
26.4" 2.8kg/m2, SBP/DBP 119.8" 9.6/78.9" 6.4mm Hg, CrCl 90.9"
18.2mL/min (M"SD). The HPT incidence in 8 years was 52%. The
participants who developed HPT (group A) compared with those who did
not (group B) had higher baseline SBP (122.4" 8.4mm Hg vs 117.0" 10.0,
p< 0.0001), DBP (80.6" 5.6 VS 77.1" 6.7mm Hg, p< 0.0001), BMI
(27.0" 2.9 vs 25.9" 2.6 kg/m2, p< 0.0001) and fractional proximal reabsorp-
tion of sodium (75.8" 6.3 vs 73.8" 7.3 %, p! 0.01). At logistic regression
analysis using standardised variables, a 1SD-higher proximal sodium reabsorp-
tion at baseline predicted a 44%greater risk ofHPTin 8 years (95%C.I. 13–84,
p! 0.003), independently of baseline SBP (OR: 1.88, 95% C.I. 1.43–2.47,
p< 0.001), BMI (OR: 1.51, 95% C.I. 1.16–1.95, p! 0.002), age and creatinine
clearance used as an index of glomerular filtration rate.
Conclusions: In this sample of healthy adult male population, proximal
sodium reabsorption indexed to glomerular filtration rate was an indepen-
dent predictor of future HPT.
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HIGH-SALT DIETS IN CHRONIC KIDNEY
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J. Quelhas Dos Santos, B. Sampaio-Maia, L. Simões-Silva, C. Fernandes-
Cerqueira, M. Pestana. 1Unit of Research and Development of Nephrology, Faculty
of Medicine, University of Porto, Porto, Portugal, 2Faculty of Dental Medicine,
University of Porto, Porto, Portugal
Renalase, a new regulator of cardiac function and blood pressure (BP), is a
monoamine oxidase secreted into blood mainly by the kidney but also by the
heart and other tissues. A reduced renalase expression was described in
patients and in animal models of chronic kidney disease (CKD) and
hypertension. In addition, the renalase knockout mouse is hypertensive
and exquisitely sensitive to cardiac ischemia. The aim of the present study
was to examine the influence of high sodium intake (HS) on renal and cardiac
expression of renalase in rats submitted to 3/4 nephrectomy (3/4nx) and
Sham surgery (Sham).
Ten days after surgery, 3/4nx and Sham animals received a normal (NS) or a
HS diet (40mmol/kg/day) during four days. BP and heart rate (HR) were
measured daily using a photoelectric tail-cuff pulse detector. Fourteen days
after surgery the animals were sacrificed and left ventricle (LV) and renal
cortex (RC) were collected for protein quantification by Western-blotting
using the anti-renalase polyclonal primary antibody (1:200, Abcam, UK). In
addition, cardiac morphometry and transversal cardiomyocyte diameter
(TCD) were also evaluated in all groups.
BP, HR and TCD were significantly increased in 3/4nx rats throughout the
study. In addition, HS diet significantly increased BP, HR and TCD in both
3/4nx and Sham rats. During NS diet the dimmer form of renalase was
significantly reduced in both RC and LV from 3/4nx rats whereas during HS
diet bothmonomer and dimmer renalase forms were reduced in both RC and
LV from 3/4nx rats. Moreover, HS diet significantly decreased both mono-
mer and dimmer renalase isoforms in the LV from 3/4nx rats when compared
with NS intake.
Our results show that the reduced renalase expression in the LV from 3/4nx
rats is further accentuated during HS intake. It is suggested that this may
contribute to the increased sodium-sensitivity of BP and enhanced cardio-
vascular risk in CKD.
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